Latent tuberculous infection: Ethical considerations in formulating public health policy

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 2, 2015, Pages 137-140

  Denholm, J T ^a,b   Matteelli, A ^c   Reis, A ^c  

^a PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Consent; Ethics; Migration; Risk; Screening

Indexed keywords

TUBERCULOSTATIC AGENT;

BACTERIAL TRANSMISSION; COMMUNITY CARE; CONSULTATION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; INFORMED CONSENT; LATENT TUBERCULOSIS; MANDATORY TESTING; MEDICAL ETHICS; MIGRANT; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCREENING TEST; MANAGEMENT;

ETHICS, MEDICAL; HEALTH POLICY; HUMANS; LATENT TUBERCULOSIS; POLICY MAKING;

EID: 84937125449     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0543     Document Type: Review

References (24)

1. Mack U, Migliori G, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956-973.
2. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M C. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 1999; 282: 677-686.
3. Horsburgh C R, O'Donnell M, Chamblee S, et al. Revisiting rates of reactivation tuberculosis. Am J Respir Crit Care Med 2010; 182: 420-425.
4. Jeon C Y, Murray M B. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLOS MED 2008; 5: e152.
5. World Health Organization. Guidelines for the management of latent tuberculosis infection.WHO/HTM/TB/2015.01. Geneva, Switzerland: WHO,2015. http://www.who.int/tb/publications/Hbi-document-pape/en Accessed December 2014.
6. Delogu G, Goletti D. The spectrum of tuberculosis infection: new perspectives in the era of biologics. J Rheumatol 2014; 91: 11-16.
7. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a wholeblood interferon-gamma release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 2011; 183: 88-95.
8. Adetifa I M, Ota M O C, Jeffries D J, et al. Interferon-c ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection. Am J Respir Crit Care Med 2013; 187: 439-445.
9. Nolan C, Goldberg S, Buskin S. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 1999; 281: 1014-1018.
10. Farmer P. Rethinking medical ethics: a view from below. Develop World Bioethics 2004; 4: 17-41.
11. Ricks P M, Cain K P, Oeltmann J E, Kammerer J S, Moonan P K. Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the US, 2005-2009. PLOS ONE 2011; 6: e27405.
12. Greenaway C, Sandoe A, Vissandjee B, et al. Tuberculosis: evidence review for newly arriving immigrants and refugees. Can Med Assoc J 2011; 183: E939-E951.
13. Denholm J T, McBryde E S. Can Australia eliminate TB? Modelling immigration strategies for reaching MDG targets in a low-transmission setting. Aust NZ J Public Health 2014; 38: 78-82.
14. Denholm J T, McBryde E S, Brown G V. Ethical evaluation of immigration screening policy for latent tuberculosis infection. Aust NZ J Public Health 2012; 36: 325-328.
15. Baussano I, Nunn P, Williams B, Pivetta E, Bugiani M, Scano F. Tuberculosis among health care workers. Emerg Infect Dis 2011; 17: 488-494.
16. van Delden J J, Ashcroft R, Dawson A, Marckmann G, Upshur R, Verweij M. The ethics of mandatory vaccination against influenza for health care workers. Vaccine 2008; 26: 5562-5566.
17. WhiteMC, Duong TM, Cruz E S, et al. Strategies for effective education in a jail setting: the Tuberculosis Prevention Project. Health Promot Pract 2003; 4: 422-429.
18. Gilson L. Trust and the development of health care as a social institution. Soc Sci Med 2003; 56: 1453-1468.
19. Hill L, Blumberg E, Sipan C, et al. Multi-level barriers to LTBI treatment: a research note. J Immigrant Minority Health 2010; 12: 544-550.
20. World Health Organization. Guidance on ethics of tuberculosis prevention, care and control. WHO/HTM/TB/2010.16. Geneva, Switzerland: WHO, 2010. www.who.int/tb/publications/2010/en/index.html
21. Denholm J T, Leslie D, Jenkin G A, et al. Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995-2010. Int J Tuberc Lung Dis 2012; 16: 1320-1325.
22. Seddon J A, Hesseling A C, Finlayson H, et al. Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study. Clin Infect Dis 2013; 57: 1676-1684.
23. Childress J F, Faden R R, Gaare R D, et al. Public health ethics: mapping the terrain. J Law Med Ethics 2002; 30: 170-178.
24. Kass N E. An ethics framework for public health. Am J Public Health 2001; 91: 1776-1782.